A pharmacogenomics study pointed out that in GBM, CBD tumor suppression properties proceeded from preventing NF-κB subunit RELA phosphorylation on serine-311 and promoting RELA DNA binding [21]. This evidence concerns the gene RELA and glioblastoma.